Artificial Cells, Nanomedicine, and Biotechnology (Dec 2024)

Green synthesized silver nanoparticles of Terminalia bellirica leaves extract: synthesis, characterization, in-silico studies, and antimalarial activity

  • Sujeet Singh,
  • Hemant Arya,
  • Welka Sahu,
  • K. Sony Reddy,
  • Surendra Nimesh,
  • Bader Saud Alotaibi,
  • Mohammed Ageeli Hakami,
  • Hassan H. Almasoudi,
  • Khater Balatone Gezira Hessien,
  • Mohammad Raghibul Hasan,
  • Summya Rashid,
  • Tarun Kumar Bhatt

DOI
https://doi.org/10.1080/21691401.2024.2339429
Journal volume & issue
Vol. 52, no. 1
pp. 238 – 249

Abstract

Read online

AbstractMalaria is a mosquito-borne infectious disease that is caused by the Plasmodium parasite. Most of the available medication are losing their efficacy. Therefore, it is crucial to create fresh leads to combat malaria. Green silver nanoparticles (AgNPs) have recently attracted a lot of attention in biomedical research. As a result, green mediated AgNPs from leaves of Terminalia bellirica, a medicinal plant with purported antimalarial effects, were used in this investigation. Initially, cysteine-rich proteins from Plasmodium species were studied in silico as potential therapeutic targets. With docking scores between −9.93 and −11.25 kcal/mol, four leaf constituents of Terminalia bellirica were identified. The green mediated silver nanoparticles were afterward produced using leaf extract and were further examined using UV-vis spectrophotometer, DLS, Zeta potential, FTIR, XRD, and FESEM. The size of synthesized TBL-AgNPs was validated by the FESEM results; the average size of TBL-AgNPs was around 44.05 nm. The zeta potential study also supported green mediated AgNPs stability. Additionally, Plasmodium falciparum (3D7) cultures were used to assess the antimalarial efficacy, and green mediated AgNPs could effectively inhibit the parasitized red blood cells (pRBCs). In conclusion, this novel class of AgNPs may be used as a potential therapeutic replacement for the treatment of malaria.

Keywords